Dear Faculty, Staff and Students,
Please see below an announcement from Mary Burke, Vice President for Institutional Advancement for Temple University naming Georgeann Moore as Katz's permanent Assistant Dean of Development and Alumni Relations. Georgeann’s dedication and influence have been instrumental to advancing our mission. Throughout her tenure here, she has built impactful relationships, aligning donor passion with the school’s strategic goals and fundraising priorities. Her work has strengthened our ability to drive forward Katz’s vision for advancing medical education, research and patient care, and we look forward to all that she will continue to accomplish on behalf of our school and alumni.
Please join me in congratulating Georgeann as she steps into this well-deserved role.
Sincerely,
Amy J. Goldberg, MD, FACS
The Marjorie Joy Katz Dean
Lewis Katz School of Medicine
|
|
A team at the Lewis Katz School of Medicine at Temple University, part of Temple Health, has been awarded nearly $1 million by the Patient-Centered Outcomes Research Institute (PCORI) to help improve antibiotic prescribing for children with acute respiratory tract infections.
“Many children with symptoms of upper respiratory tract illness who are taken to see a pediatrician end up being prescribed antibiotics, even though they aren’t always needed,” explained Janet Lee, MD, Associate Professor of Pediatrics, Lewis Katz School of Medicine. Dr. Lee and Claire Raab, MD, President and CEO of Temple Faculty Physicians, will co-lead the new PCORI initiative.
“Working with physicians and families, we want to contextualize for the community the significance of inappropriate antibiotic use and potential for antibiotic resistance,” Lee explained. Assuring appropriate antibiotic prescribing and use in pediatric populations can help prevent drug-resistant infections and avoid adverse side effects.
“Thanks to the new funding award, Dr. Lee and I can now spearhead vital progress toward greater antibiotic stewardship,” Dr. Raab said. “This funding will enable us to conduct groundbreaking work that will significantly benefit our community. The initiative also aligns perfectly with our commitment to evidence-based care.”
"The funding from PCORI further strengthens our mission at the Lewis Katz School of Medicine to deliver care that is both innovative and deeply rooted in the needs of our community," said Amy J. Goldberg, MD, FACS, The Marjorie Joy Katz Dean, Lewis Katz School of Medicine. "We are proud to lead initiatives that improve clinical outcomes and engage families and clinicians in ways that make care more accessible and effective for our youngest patients."
“This PCORI funding award will support Temple Health in promoting antibiotic stewardship for children with acute respiratory tract infections,” said PCORI Executive Director Nakela L. Cook, MD, MPH. “This project exemplifies PCORI's commitment to advancing the uptake of evidence into health care delivery settings to enable parents, caregivers and clinicians to make informed health care decisions and improve care delivery and health outcomes. We look forward to following the project’s progress and collaborating with Temple Health to share its results.”
In a previous PCORI-funded patient-centered comparative clinical effectiveness research (CER) study, researchers found that broad-spectrum antibiotics carry a greater risk of side effects relative to narrow-spectrum antibiotics, even though the two are equally effective in treating acute respiratory tract infections in children. The new initiative aims to implement and leverage these findings to improve antibiotic prescribing and stewardship.
“Along with implementing prior research to decrease broad-spectrum antibiotic use, we also are involving patients and families in focus groups and engaging with providers who see adult patients to help elevate the pediatric voice and guide messaging on antibiotic use,” Dr. Lee explained. Ultimately, these efforts could help delay the prescribing of antibiotics until their use is deemed absolutely necessary.
Temple Health is a participant in PCORI’s Health Systems Implementation Initiative (HSII) and was selected for funding through a PCORI opportunity in which HSII participants were recruited to promote evidence-based practice, based on findings generated from PCORI-funded patient-centered CER. HSII aims to reduce the estimated 17-year gap between evidence publication and clinical application. The initiative recognizes that practical experience and real-world insights acquired in diverse health care settings and health systems are crucial for sustainable, large-scale implementation of practice-changing findings in clinical care.
The funding support for Drs. Lee and Raab has been approved pending completion of PCORI’s business and programmatic review and issuance of a formal award contract.
PCORI is an independent, nonprofit organization authorized by Congress with a mission to fund patient-centered comparative clinical effectiveness research that provides patients, their caregivers and clinicians with the evidence-based information they need to make better-informed health and health care decisions.
Dear Colleagues,
I am pleased to announce the latest addition to the Dean's Office at the Lewis Katz School of Medicine. Please join me in welcoming Katie Griffin as our new Executive Assistant to the Dean. I would also like to recognize and thank Michaela Baus for her tremendous support during this transition.
Already a member of our Temple family, Katie brings over 20 years of dedicated experience in administrative roles within higher education, streamlining processes, enhancing communications and supporting senior leadership. Most recently, Katie served as the Executive Assistant to Temple’s Vice President of Strategic Marketing and Communications, where she provided high-level executive support and played a key role in office operations, HR processes, and financial management. Prior to her work at SM+C, she spent six years at the Lewis Katz School of Medicine in the Office of Institutional Advancement, where she was involved in managing Board of Visitors meetings and supporting key development initiatives.
In her new role as Executive Assistant to the Dean, Katie will report to Kendra Kirk, Associate Vice Dean, Strategic Initiatives and Chief of Staff, and manage Michaela and Sharri Reese-Banks. She will lead the Dean’s Office administration to ensure the efficient functioning of the office and be a key liaison between the Dean’s Office and internal and external partners.
We are excited to have Katie join us and are confident that her skills and experience will greatly contribute to the school’s continued success. Please join me in welcoming her back to Katz.
Sincerely,
Amy J. Goldberg, MD, FACS
The Marjorie Joy Katz Dean
Lewis Katz School of Medicine
Dear Faculty, Staff and Students,
I am pleased to announce the appointment of Laurie Kilpatrick, PhD, as Associate Dean of Research at the Lewis Katz School of Medicine. Dr. Kilpatrick has been a dedicated member of the Temple community since 2009, during which time she has held numerous key roles, including Assistant Dean for Clinical Research and faculty appointments in the Departments of Microbiology, Immunology, and Inflammation, and Thoracic Medicine and Surgery.
Dr. Kilpatrick is a recognized leader in vascular inflammation, sepsis, and acute lung injury research, having authored over 90 peer-reviewed papers. She has also held prominent positions such as President of the Shock Society, an international society promoting clinically relevant research into the basic biology of trauma, shock, and sepsis, and served on several National Institutes of Health (NIH) study sections.
She has also served as an Ad Hoc member of the NIH National Institute of General Medical Sciences Council. Her groundbreaking work on sepsis treatments and neutrophil-endothelial interactions continues to shape the future of inflammatory disease therapies.
In addition to her research achievements, Dr. Kilpatrick has been instrumental in developing strategies and infrastructure to support the growth and development of clinical research – a vital component of the Katz School’s overall research enterprise. She worked with various teams at Temple to establish the Katz BioBank in 2022, and this year she helped launch the CollabConnect research partnership development program, designed to foster increased collaboration among Katz researchers.
As Associate Dean of Research, Dr. Kilpatrick will collaborate with Erica Golemis, PhD, Senior Associate Dean for Research, to provide leadership and strategic oversight for our school’s research activities. She will help develop a clinical research strategy, evaluate research productivity, and ensure faculty have the resources they need to succeed alongside supporting faculty career development. We are confident that Dr. Kilpatrick’s leadership will continue to advance our research mission by fostering a vibrant research environment across Temple.
Please join me in congratulating Dr. Kilpatrick on her well-deserved appointment.
Sincerely,
Amy J. Goldberg, MD, FACS
The Marjorie Joy Katz Dean
Lewis Katz School of Medicine